SARS-CoV-2 (COVID-19) Virus Antibody Research
ProSci Incorporated has developed and manufactured SARS-CoV-2 (COVID-19, 2019-nCoV) antibodies, antigens, and other reagents related to cellular entry: ACE2 receptor, TMPRSSR2 protease, and furin enzyme. ProSci Inc. is continuously adding new SARS-CoV-2 reagents for spike, S1, S2, nucleocapsid, membrane, envelope including llama single domain antibodies and recombinant proteins.
SARS-CoV-2 Featured Products
|
||
---|---|---|
COVID-19 Patient Validated Cat. No: 9099 SARS-CoV-2 (COVID-19) Nucleocapsid Antibody |
COVID-19 Patient Validated |
COVID-19 Patient Validated |
For a complete list of SARS-CoV-2 research product portfolio, visit us at prosci-inc.com |
DBA-ITALIA Srl
Via Umbria 10
20054 Segrate (Milano)
Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535